ANALYSIS OF SYNERGY BETWEEN CYCLOPHOSPHAMIDE THERAPY AND IMMUNITY AGAINST A MOUSE TUMOR

被引：33

作者：

CHASSOUX, DM ^{[1
]}

GOTCH, FM ^{[1
]}

MACLENNAN, ICM ^{[1
]}

机构：

[1] RADCLIFFE INFIRM,NUFFIELD DEPT CLIN MED,OXFORD OX2 6HE,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1978年 / 38卷 / 02期

关键词：

D O I：

10.1038/bjc.1978.190

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：211 / 218

页数：8

共 21 条

[1] FACTOR TIME FOR ACTIVE IMMUNOTHERAPY AFTER CYTOREDUCTIVE CHEMOTHERAPY
AMIEL, JL
BERARDET, M
[J]. EUROPEAN JOURNAL OF CANCER, 1974, 10 (02) : 89 - 91
[2] ASKENASE PW, 1975, J EXP MED, V141, P698
[3] BERENBAUM MC, 1975, CLIN ASPECTS IMMUNOL, P689
[4] ACTIVE SPECIFIC IMMUNOTHERAPY OF MOUSE METHYLCHOLANTHRENE INDUCED TUMORS WITH CORYNEBACTERIUM-PARVUM AND IRRADIATED TUMOR-CELLS
BOMFORD, R
[J]. BRITISH JOURNAL OF CANCER, 1975, 32 (05) : 551 - 557
[5] COMPETITION FOR CYTOTOXIC IMMUNE CAPACITY AGAINST A SYNGENEIC MOUSE TUMOR DISTRIBUTED AT 2 SITES
CHASSOUX, D
MACLENNAN, ICM
MUNRO, TR
[J]. INTERNATIONAL JOURNAL OF CANCER, 1977, 19 (06) : 796 - 802
[6] ACTIVE IMMUNOTHERAPY WITH CORYNEBACTERIUM PARVUM AND CHEMOTHERAPY IN MURINE FIBROSARCOMAS
CURRIE, GA
BAGSHAWE, KD
[J]. BRITISH MEDICAL JOURNAL, 1970, 1 (5695) : 541 - &
[7] ASSESSMENT OF DRUG SENSITIVITY OF HUMAN LEUKEMIC MYELOBLASTS .1. LABELING HUMAN MYELOBLASTS WITH (IUDR)-I-125 FOR SURVIVAL STUDIES IN MICE
FALCAO, RP
SONIS, S
MACLENNAN, ICM
CHASSOUX, D
DAVIES, AJS
MUNRO, TR
[J]. BRITISH JOURNAL OF CANCER, 1977, 36 (03) : 297 - 306
[8] CYCLOPHOSPHAMIDE PRETREATMENT AND PROTECTION AGAINST MALARIA
FINERTY, JF
KREHL, EP
[J]. INFECTION AND IMMUNITY, 1976, 14 (04) : 1103 - 1105
[9] FURTHER OBSERVATIONS ON INHIBITION OF TUMOR-GROWTH BY CORYNEBACTERIUM-PARVUM WITH CYCLOPHOSPHAMIDE .1. VARIATION IN ADMINISTRATION OF BOTH AGENTS
FISHER, B
WOLMARK, N
RUBIN, H
SAFFER, E
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (05) : 1147 - 1153
[10] GOTOHDA E, 1974, CANCER RES, V34, P1947

← 1 2 3 →